COMBI PACK ANTI - A, B & D MONOCLONAL - India CDSCO Medical Device Registration

COMBI PACK ANTI - A, B & D MONOCLONAL is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000005_959db901c0ae955060370805d6ed678a_dc367856bbe2e6571f7670570a0051cb. This device is marketed under the brand name IgM+IgG. The license holder is Dhiti Diagnostics Private Limited, and it is classified as Device Class Class D. The approving authority is CDSCO -North Zone, Ghaziabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class D

COMBI PACK ANTI - A, B & D MONOCLONAL

UID: MFG/IVD/2022/000005_959db901c0ae955060370805d6ed678a_dc367856bbe2e6571f7670570a0051cb

Brand Name

IgM+IgG

License Holder

Dhiti Diagnostics Private Limited

Device Class

Class D

Approving Authority

CDSCO -North Zone, Ghaziabad

Product Information

The Combi pack Anti - A, B & D (IgM+IgG) Monoclonal reagent consists of Monoclonal blood, grouping Anti-A, Anti-B, and Anti-D (IgM+IgG) reagents. These reagents are used for in vitro determination of presence or absence of A, B, and D antigens in red cells of human blood.